FDA and NIH Agree on Framework for Collaboration on Neurological Disorders

Summary

The US Food and Drug Administration (FDA) and the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NIH/NINDS) have signed a Memorandum of Understanding (MOU) to enhance coordination and information sharing on neurological disorders, building on their roles as part of the Department of Health and Human Services.